Aidian – QuikRead go CRP
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
C-reactive protein (CRP) is a widely used analyte in healthcare, but do you know why it’s beneficial to measure CRP using point-of-care (POC) testing?
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
C-reactive protein (CRP) is a widely used analyte in healthcare, but do you know why it’s beneficial to measure CRP using point-of-care (POC) testing?
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Haemoglobinopathies, such as sickle cell disease and alpha/beta thalassemia major, are prevalent genetic disorders that affect the protein part of haemoglobin (Hb).
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
VALIDATE® Hemostatsis – Linearity and Calibration Verification Test Kits for Clinical Analysers
THESE PRODUCTS ARE NOT AVAILABLE FOR PURCHASE BY THE GENERAL PUBLIC.
Sebia FLC Kappa and Sebia FLC Lambda – Measurement of FLC can be complex and challenging for many laboratories using traditional turbidimetric or nephelometric methods.
Products are for professional/laboratory use only.
IDS cartilage markers, supporting early identification of cartilage damage by providing dynamic assessment of cartilage destruction.
Products are for professional/laboratory use only.
Early diagnosis of knee osteoarthritis (OA) remains a diagnostic challenge.
Urinary C-terminal crosslinked telopeptide of type II collagen (urinary CTX-II) is one of the potential OA biomarkers.
Products are for professional/laboratory use only.
Abacus dx is pleased to announce the launch of UTAK products, 100% Real Quality Controls.
Products are for professional/laboratory use only.
LGC Maine Standards is a market leader for linearity and calibration verification products.
Products are for professional/laboratory use only.
As distributors of a comprehensive portfolio in clinical diagnostics and functional medicine, we have been able to meet our customers’ specific needs, propose solutions to their problems, and orientate them towards the innovation path in IVD.